Placebo Versus Allopurinol for Renal Calculi
Author:
- 1 June 1977
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 117 (6) , 690-692
Abstract
Certain patients with recurrent calcium oxalate calculi will show a mild uricacidemia and/or uricosuria. A prospective blind study was begun in 1970, comparing placebo to allopurinol in the management of these patients. The 92 patients had been followed for a minimum of 6 months to 5 years before the code was broken. It is demonstrated clearly that there is a placebo effect in the management of renal calculous disease. It also has been shown that the only event that clearly separates the 2 groups is complete cessation of calculous formation. Allopurinol is effective in 61 per cent of the patients and these successes usually can be identified after 1 year of treatment.Keywords
This publication has 7 references indexed in Scilit:
- Saturation-Inhibition Index as a Measure of the Risk of Calcium Oxalate Stone Formation in the Urinary TractNew England Journal of Medicine, 1976
- Heterogeneous Nucleation of Calcium Oxalate by Seeds of Monosodium UrateExperimental Biology and Medicine, 1975
- Hypercalciuria and Hyperuricosuria in Patients with Calcium NephrolithiasisNew England Journal of Medicine, 1974
- ALLOPURINOL TREATMENT OF URIC-ACID DISORDERS IN CALCIUM-STONE FORMERSThe Lancet, 1973
- Allopurinol and UrolithiasisJournal of Urology, 1969
- Uricemia and UrolithiasisJournal of Urology, 1969
- Urinary Xanthine Stones-a Rare Complication of Allopurinol TherapyNew England Journal of Medicine, 1969